These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15613549)

  • 1. EBV latent membrane protein-1 protects B cells from apoptosis by inhibition of BAX.
    Grimm T; Schneider S; Naschberger E; Huber J; Guenzi E; Kieser A; Reitmeir P; Schulz TF; Morris CA; Stürzl M
    Blood; 2005 Apr; 105(8):3263-9. PubMed ID: 15613549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2.
    Takeshita H; Yoshizaki T; Miller WE; Sato H; Furukawa M; Pagano JS; Raab-Traub N
    J Virol; 1999 Jul; 73(7):5548-55. PubMed ID: 10364303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus latent membrane protein 1 induces CD69 expression through activation of nuclear factor-κB.
    Ishikawa C; Mori N
    Int J Oncol; 2013 May; 42(5):1786-92. PubMed ID: 23546309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of epidermal growth factor receptor expression by Epstein-Barr virus latent membrane protein 1 C-terminal-activating region 1 is mediated by NF-kappaB p50 homodimer/Bcl-3 complexes.
    Thornburg NJ; Raab-Traub N
    J Virol; 2007 Dec; 81(23):12954-61. PubMed ID: 17881446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transactivation of CCL20 gene by Epstein-Barr virus latent membrane protein 1.
    Okudaira T; Yamamoto K; Kawakami H; Uchihara JN; Tomita M; Masuda M; Matsuda T; Sairenji T; Iha H; Jeang KT; Matsuyama T; Takasu N; Mori N
    Br J Haematol; 2006 Feb; 132(3):293-302. PubMed ID: 16409294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-kappaB pathway.
    Gatto G; Rossi A; Rossi D; Kroening S; Bonatti S; Mallardo M
    Nucleic Acids Res; 2008 Nov; 36(20):6608-19. PubMed ID: 18940871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of nuclear factor kappaB binding sites in the murine bcl-x promoter.
    Glasgow JN; Wood T; Perez-Polo JR
    J Neurochem; 2000 Oct; 75(4):1377-89. PubMed ID: 10987817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.
    Mori N; Morishita M; Tsukazaki T; Yamamoto N
    Int J Cancer; 2003 Jul; 105(5):661-8. PubMed ID: 12740915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP-1) gene and promoter in Hodgkin's disease isolates: selection against EBV variants with mutations in the LMP-1 promoter ATF-1/CREB-1 binding site.
    Sandvej K; Andresen BS; Zhou XG; Gregersen N; Hamilton-Dutoit S
    Mol Pathol; 2000 Oct; 53(5):280-8. PubMed ID: 11091852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.
    D'Souza BN; Edelstein LC; Pegman PM; Smith SM; Loughran ST; Clarke A; Mehl A; Rowe M; Gélinas C; Walls D
    J Virol; 2004 Feb; 78(4):1800-16. PubMed ID: 14747545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor through effects on Bcl-3 and STAT3.
    Kung CP; Raab-Traub N
    J Virol; 2008 Jun; 82(11):5486-93. PubMed ID: 18367518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ kappa-dependent pathway.
    Pegman PM; Smith SM; D'Souza BN; Loughran ST; Maier S; Kempkes B; Cahill PA; Simmons MJ; Gélinas C; Walls D
    J Virol; 2006 Aug; 80(16):8133-44. PubMed ID: 16873269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of two NF-kappa B binding elements in tumor necrosis factor alpha -, CD40-, and epstein-barr virus latent membrane protein 1-mediated induction of the cellular inhibitor of apoptosis protein 2 gene.
    Hong SY; Yoon WH; Park JH; Kang SG; Ahn JH; Lee TH
    J Biol Chem; 2000 Jun; 275(24):18022-8. PubMed ID: 10751398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear factor-kappaB binds to the Epstein-Barr Virus LMP1 promoter and upregulates its expression.
    Johansson P; Jansson A; Rüetschi U; Rymo L
    J Virol; 2009 Feb; 83(3):1393-401. PubMed ID: 19019967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of constitutive and tumor necrosis factor alpha-induced nuclear factor (NF)-kappaB activation and induction of apoptosis by apigenin in human prostate carcinoma PC-3 cells: correlation with down-regulation of NF-kappaB-responsive genes.
    Shukla S; Gupta S
    Clin Cancer Res; 2004 May; 10(9):3169-78. PubMed ID: 15131058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The function of multiple IkappaB : NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis.
    Dong QG; Sclabas GM; Fujioka S; Schmidt C; Peng B; Wu T; Tsao MS; Evans DB; Abbruzzese JL; McDonnell TJ; Chiao PJ
    Oncogene; 2002 Sep; 21(42):6510-9. PubMed ID: 12226754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of nuclear factor-kappaB p50 homodimer/Bcl-3 complexes in nasopharyngeal carcinoma.
    Thornburg NJ; Pathmanathan R; Raab-Traub N
    Cancer Res; 2003 Dec; 63(23):8293-301. PubMed ID: 14678988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular signaling molecules activated by Epstein-Barr virus for induction of interferon regulatory factor 7.
    Zhang L; Wu L; Hong K; Pagano JS
    J Virol; 2001 Dec; 75(24):12393-401. PubMed ID: 11711629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antisense to the epstein-barr virus (EBV)-encoded latent membrane protein 1 (LMP-1) suppresses LMP-1 and bcl-2 expression and promotes apoptosis in EBV-immortalized B cells.
    Kenney JL; Guinness ME; Curiel T; Lacy J
    Blood; 1998 Sep; 92(5):1721-7. PubMed ID: 9716601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.